Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-01-01 @ 4:34 AM
Study NCT ID:
NCT04176367
Status:
COMPLETED
Last Update Posted:
2021-01-27
First Post:
2019-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-06
First Submit QC Date:
None
Study First Post Date:
2019-11-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-01-27
Last Update Post Date Type:
ACTUAL